59
Views
32
CrossRef citations to date
0
Altmetric
Review

VH3-21 Gene Usage in Chronic Lymphocytic Leukemia – Characterization of a New Subgroup with Distinct Molecular Features and Poor Survival

, , &
Pages 221-228 | Received 03 May 2003, Published online: 03 Aug 2009

References

  • Matutes, E., Owusu-Ankomah, K., Morilla, R., Garcia Marco, J., Houlihan, A., Que, T.H., et al. (1994) "The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL", Leukemia, 8, 1640— 1645.
  • Binet, J.L., Auquier, A., Dighiero, G., Chastang, C., Piguet, H., Goasguen, J., et al. (1981) "A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis", Cancer, 48, 198 —206.
  • Rai, K.R., Sawitsky, A., Cronkite, E.P., Chanana, A.D., Levy, R.N. and Pasternack, B.S. (1975) "Clinical staging of chronic lympho-cytic leukemia", Blood, 46, 219 — 234.
  • Damle, R.N., Wasil, T., Fais, F., Ghiotto, F., Valetto, A., Allen, S.L., et al. (1999) "Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia", Blood, 94, 1840— 1847.
  • Hamblin, T.J., Davis, Z., Gardiner, A., Oscier, D.G. and Stevenson, F.K. (1999) "Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia [see comments]", Blood, 94, 1848 — 1854.
  • Thunberg, U., Johnson, A., Roos, G., Thorn, I., Tobin, G., Sallstrom, J., et al. (2001) "CD38 expression is a poor predictor for VH gene mutational status and prognosis in chronic lymphocytic leukemia", Blood, 97, 1892— 1894.
  • Maloum, K., Davi, F., Merle-Beral, H., Pritsch, O., Magnac, C., Vuillier, F., et al. (2000) "Expression of unmutated VH genes is a detrimental prognostic factor in chronic lymphocytic leukemia", Blood, 96, 377 — 379.
  • Cook, G.P. and Tomlinson, I.M. (1995) "The human immunoglo-bulin VH repertoire" Immunology Today, 16, 237 — 242.
  • Lefranc, M.-P. (2000) in: "Locus maps and genomic repertoire of the human Ig genes", The Immunologist, pp. 80–87.
  • Lefranc, M.-P. and Lefranc, G. (2001) The Immunoglobulin Facts-book. London: Academic Press, Hartcourt Publishers Limited.
  • Bassing, C.H., Swat, W. and Alt, F.W. (2002) "The mechanism and regulation of chromosomal V(D)J recombination", Cell, 109 Suppl, S45—S55.
  • Oettinger, MA., Schatz, D.G., Gorka, C. and Baltimore, D. (1990) "RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination", Science, 248, 1517 — 1523.
  • Kitamura, D., Kudo, A., Schaal, S., Muller, W., Melchers, F. and Rajewsky, K. (1992) "A critical role of lambda 5 protein in B cell development", Cell, 69, 823–831.
  • Papavasiliou, F.N. and Schatz, D.G. (2002) "Somatic hypermuta-tion of immunoglobulin genes: merging mechanisms for genetic diversity", Cell, 109 Suppl, S35—S44.
  • Dorner, T., Foster, S.J., Farner, N.L. and Lipsky, P.E. (1998) "Somatic hypermutation of human immunoglobulin heavy chain genes: targeting of RGYW motifs on both DNA strands", European Journal of Immunology, 28, 3384–3396.
  • Klein, U., Rajewsky, K. and Kuppers, R. (1998) "Human immu-noglobulin (Ig)M + IgD + peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells", Journal of Experimental Medicine, 188, 1679 — 1689.
  • Thorselius, M., Walsh, S., Eriksson, I., Thunberg, U., Johnson, A., Backlin, C., et al. (2002) "Somatic hypermutation and V(H) gene usage in mantle cell lymphoma", European Journal of Haematology, 68, 217–224.
  • Rettig, MB., Vescio, R.A., Cao, J., Wu, C.H., Lee, J.C., Han, E., et al. (1996) "VH gene usage is multiple myeloma: complete absence of the VH4.21 (VH4-34) gene", Blood, 87, 2846–2852.
  • Bahler, D.W., Campbell, Mi., Hart, S., Miller, R.A., Levy, S. and Levy, R. (1991) "Ig VH gene expression among human follicular lymphomas", Blood, 78, 1561 — 1568.
  • Cleary, ML., Meeker, T.C., Levy, S., Lee, E., Trela, M., Sklar, J., et al. (1986) "Clustering of extensive somatic mutations in the variable region of an immunoglobulin heavy chain gene from a human B cell lymphoma", Cell, 44, 97–106.
  • Zhu, D., Hawkins, RE., Hamblin, T.J. and Stevenson, F.K. (1994) "Clonal history of a human follicular lymphoma as revealed in the immunoglobulin variable region genes", British Journal of Haema-tology, 86, 505 —512.
  • Kuppers, R., Rajewsky, K. and Hansmann, M.L. (1997) "Diffuse large cell lymphomas are derived from mature B cells carrying V region genes with a high load of somatic mutation and evidence of selection for antibody expression", European Journal of Immunology, 27, 1398–1405.
  • Ottensmeier, C.H., Thompsett, AR., Zhu, D., Wilkins, B.S., Sweetenham, J.W. and Stevenson, F.K. (1998) "Analysis of VH genes in follicular and diffuse lymphoma shows ongoing somatic mutation and multiple isotype transcripts in early disease with changes during disease progression", Blood, 91, 4292–4299.
  • Lossos, IS., Alizadeh, A.A., Eisen, MB., Chan, W.C., Brown, P.O., Botstein, D., et al. (2000) "Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas", Proceedings of the National Academy of Sciences of the USA, 97, 10209 — 10213.
  • Klein, U., Klein, G., Ehlin-Henriksson, B., Rajewsky, K. and Kuppers, R. (1995) "Burkitt's lymphoma is a malignancy of mature B cells expressing somatically mutated V region genes", Molecular Medicine, 1, 495–505.
  • Tamaru, J., Hummel, M., Marafioti, T., Kalvelage, B., Leoncini, L., Minacci, C., et al. (1995) "Burkitt's lymphomas express VH genes with a moderate number of antigen-selected somatic mutations", American Journal of Pathology, 147, 1398–1407.
  • Tierens, A., Delabie, J., Malecka, A., Wang, J., Gruszka-Westwood, A., Catovsky, D., et al. (2003) "Splenic marginal zone lymphoma with villous lymphocytes shows on-going immunoglobulin gene mutations", American Journal of Pathology, 162, 681 — 689.
  • Bakkus, M.H., Heirman, C., Van Rid, I., Van Camp, B. and Thielemans, K. (1992) "Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation", Blood, 80, 2326–2335.
  • Deane, M. and Norton, J.D. (1991) "Preferential rearrangement of developmentally regulated immunoglobulin VH1 genes in human B-lineage leukaemias", Leukemia, 5, 646–650.
  • Ebeling, S.B., Schutte, ME., Akkermans-Koolhaas, K.E., Bloem, AC., Gmelig-Meyling, F.H. and Logtenberg, T. (1992) "Expression of members of the immunoglobulin VH3 gene families is not restricted at the level of individual genes in human chronic lymphocytic leukemia", International Immunology, 4, 313— 320.
  • Kipps, T.J., Tomhave, E., Pratt, L.F., Duffy, S., Chen, P.P. and Carson, D.A. (1989) "Developmentally restricted immunoglobulin heavy chain variable region gene expressed at high frequency in chronic lymphocytic leukemia", Proceedings of the National Academy of Sciences of the USA, 86, 5913–5917.
  • Schroeder, H.W., Jr. and Dighiero, G. (1994) "The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire [see comments]", Immunology Today, 15, 288 — 294.
  • Fais, F., Ghiotto, F., Hashimoto, S., Sellars, B., Valetto, A., Allen, S.L., et al. (1998) "Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors", Journal of Clinical Investigation, 102, 1515 — 1525.
  • Kröber, A., Seiler, T., Benner, A., Bullinger, L., Brückle, E., Lichter, P., et al. (2002) "VH mutation status, CD38 expression level, genomic observations and survival in chronic lymphocytic leukemia", Blood, 100, 1410–1418.
  • Oscier, D.G., Gardner, AC., Mould, S.J., Glide, S., Davis, Z.A., Ibbotson, RE., et al. (2002) "Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors", Blood, 100, 1177–1184.
  • D'Arena, G., Di Renzo, N., Brugiatelli, M., Vigliotti, M.L. and Keating, M.J. (2003) "Biological and clinical heterogeneity of B-cell chronic lymphocytic leukemia", Leukemia Lymphoma, 44, 223— 228.
  • Klein, U., Tu, Y., Stolovitzky, GA., Mattioli, M., Cattoretti, G., Husson, H., et al. (2001) "Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells", Journal of Experimental Medicine, 194, 1625–1638.
  • Rosenwald, A., Alizadeh, A.A., Widhopf, G., Simon, R., Davis, RE., Yu, X., et al. (2001) "Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia", Journal of Experimental Medicine, 194, 1639 — 1647.
  • Vilpo, J., Tobin, G., Hulkkonen, J., Hurme, M., Thunberg, U., Sundstrom, C., et al. (2003) "Surface antigen expression and correlation with variable heavy-chain gene mutation status in chronic lymphocytic leukemia", European Journal or Haematology, 70, 53–59.
  • Damle, R.N., Ghiotto, F., Valetto, A., Albesiano, E., Fais, F., Yan, Xi., et al. (2002) "B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes", Blood, 99, 4087–4093.
  • Chiorazzi, N. and Ferrarini, M. (2003) "B CELL CHRONIC LYMPHOCYTIC LEUKEMIA: Lessons Learned from Studies of the B Cell Antigen Receptor", Annu Rev Immunology, 21, 841–894.
  • Weller, S., Faili, A., Garcia, C., Braun, M.C., Le Deist, F.F., de Saint Basile, G.G., et al. (2001) "CD4O-CD4OL independent Ig gene hypermutation suggests a second B cell diversification pathway in humans", Proceedings of the National Academy of Sciences of the USA, 98, 1166 — 1170.
  • Kipps, T.J. and Carson, D.A. (1993) "Autoantibodies in chronic lymphocytic leukemia and related systemic autoimmune diseases", Blood, 81, 2475–2487.
  • Caligaris-Cappio, F. (2000) "Biology of chronic lymphocytic leukemia", Reviews in Clinical and Experimental Hematology, 4, 5 — 21.
  • Sthoeger, Z.M., Wakai, M., Tse, D.B., Vinciguerra, V.P., Allen, S.L., Budman, D.R., et al. (1989) "Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lympho-cytic leukemia", Journal of Experimental Medicine, 169, 255–268.
  • Kipps, T.J. and Duffy, S.F. (1991) "Relationship of the CD5 B cell to human tonsillar lymphocytes that express autoantibody-asso-ciated cross-reactive idiotypes", Journal of Clinical Investigation, 87, 2087 —2096.
  • Axelrod, O., Silverman, G.J., Dev, V., Kyle, R., Carson, D.A. and Kipps, T.J. (1991) "Idiotypic cross-reactivity of immunoglobulins expressed in Waldenstrom's macroglobulinemia, chronic lympho-cytic leukemia, and mantle zone lymphocytes of secondary B-cell follicles", Blood, 77, 1484 — 1490.
  • van Esch, W.J., Reparon-Schuijt, C.C., Hamstra, H.J., van Kooten, C., Logtenberg, T., Breedveld, F.C., et al. (2002) "Polyreactivity of Human IgG Fc-binding Phage Antibodies Constructed from Synovial Fluid CD38 + B Cells of Patients with Rheumatoid Arthritis", Journal of Autoimmunity, 19, 241 —250.
  • Walsh, S.H., Thorselius, M., Johnson, A., Soderberg, O., Jerkeman, M., Bjorck, E., et al. (2003) "Mutated VH genes and preferential VH3-21 usage define new subsets of mantle cell lymphoma", Blood, 101, 4047–4054.
  • Marasca, R., Vaccari, P., Luppi, M., Zucchini, P., Castelli, I., Barozzi, P., et al. (2001) "Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma", American Journal of Pathology, 159, 253–261.
  • Rosenquist, R., Lindstrom, A., Holmberg, D., Lindh, J. and Roos, G. (1999) "V(H) gene family utilization in different B-cell lymphoma subgroups", European Journal of Haematology, 62, 123–128.
  • Oscier, D.G., Thompsett, A., Zhu, D. and Stevenson, F.K. (1997) "Differential rates of somatic hypermutation in V(H) genes among subsets of chronic lymphocytic leukemia defined by chromosomal abnormalities", Blood, 89, 4153 — 4160.
  • Miklos, J.A., Swerdlow, S.H. and Bahler, D.W. (2000) "Salivary gland mucosa-associated lymphoid tissue lymphoma immunoglo-bulin V(H) genes show frequent use of V1-69 with distinctive CDR3 features", Blood, 95, 3878 — 3884.
  • Johnson, T.A., Rassenti, L.Z. and Kipps, T.J. (1997) "Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features", Journal of Immunology, 158, 235–246.
  • Tobin, G., Thunberg, U., Johnson, A., Thorn, I., Soderberg, O., Hultdin, M., et al. (2002) "Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia", Blood, 99, 2262–2264.
  • Potter, K.N., Orchard, J.A., Critchley, E., Mockridge, CI., Jose, A. and Stevenson, F.K. (2002) "Features of the over-expressed V1-69 genes in the unmutated subset of chronic lymphocytic leukemia are distinct from those in the healthy elderly repertoire", Blood, 101, 3082— 3084.
  • Tobin, G., Thunberg, U., Johnson, A., Eriksson, I., Soderberg, O., Karlsson, K., et al. (2003) "Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vtlambda12-14 gene usage and homologous CDR3s: implicating recognition of a common antigen epitope", Blood, 101, 4952–4957.
  • Naylor, M. and Capra, J.D. (1999) "Mutational status of Ig V(H) genes provides clinically valuable information in B-cell chronic lymphocytic leukemia [comment]", Blood, 94, 1837 — 1839.
  • Matrai, Z., Lin, K., Dennis, M., Sherrington, P., Zuzel, M., Pettitt, A.R., et al. (2001) "CD38 expression and Ig VH gene mutation in B-cell chronic lymphocytic leukemia", Blood, 97, 1902— 1903.
  • Nollet, F., Cauwelier, B., Billiet, J., Selleslag, D., Van Hoof, A., Louwagie, A., et al. (2002) "Do B-cell chronic lymphocytic leukemia patients with Ig VH3-21 genes constitute a new subset of chronic lymphocytic leukemia?", Blood, 100, 1097–1098; discussion 1098 — 1099.
  • Elagib, K.E., Tengner, P., Levi, M., Jonsson, R., Thompson, K.M., Natvig, J.B., et al. (1999) "Immunoglobulin variable genes and epitope recognition of human monoclonal anti-Ro 52-kd in primary Sjogren's syndrome", Arthritis and Rheumatism, 42, 2471 —2481.
  • He, X., Goronzy, ii., Zhong, W., Xie, C. and Weyand, C.M. (1995) "VH3-21 B cells escape from a state of tolerance in rheumatoid arthritis and secrete rheumatoid factor", Molecular Medicine, 1, 768–780.
  • Sasaki, M., Van De Water, J., Kenny, T.P., Gallo, M.L., Leung, P.S., Nakanuma, Y., et al. (2001) "Immunoglobulin gene usage and immunohistochemical characteristics of human monoclonal anti-bodies to the mitochondrial autoantigens of primary biliary cirrhosis induced in the XenoMouse", Hepatology, 34, 631–637.
  • Kröber, A., Benner, A., Bühler, A., Döhner, H. and Stilgenbauer, S., (2002) "Multivariate survival analysis of specific VH-genes in CLL: V3-21 and V3-23 are prognostic factors independently of the VH mutation status", Blood, 100, 196a.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.